Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)

|About: Regeneron Pharmaceutical... (REGN)|By:, SA News Editor
Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)